JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 3 484-495
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, A. M.
Right arrow Articles by Datz, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, A. M.
Right arrow Articles by Datz, F. L.

Kinetic Modeling of Teboroxime Using Dynamic SPECT Imaging of a Canine Model

Anne M. Smith, Grant T. Gullberg, Paul E. Christian and Frederick L. Datz

Department of Radiology, Division of Nuclear Medicine, Medical Imaging Research Laboratory and the Bioengineering Department, University of Utah, Salt Lake City, Utah

Correspondence: For correspondence and reprints contact: Grant T. Gullberg, PhD, Director, Medical Imaging Research Laboratory, AC213 SOM MIRL, University of Utah, Salt Lake City, UT 84132.

ABSTRACT

The tomographic utility of 99mTc-labeled teboroxime has been limited because of its fast washout from the heart, which requires rapid data acquisitions that have not been feasible until the recent development of multidetector SPECT systems. Methods: Using a three-detector SPECT system to acquire dynamic tomographic data every 10.2 sec, we investigated the potential of modeling the kinetics of teboroxime to develop a sensitive and quantitative measure of cardiac perfusion. Seven studies were performed on four dogs; in three of the studies the LAD artery was occluded. The three-dimensional activity distributions were reconstructed and were corrected for attenuation using a transmission scan. Time-activity curves from the blood and tissue were fit to a two-compartment model with two-way exchange. Results: Performing attenuation correction during the reconstruction process affected the washin parameter k21 significantly (p < 0.0001). The washin parameter k21 also decreased significantly (p < 0.002) when the LAD was occluded. Conclusions: The results indicate that the washin of teboroxime in myocardial tissue (k21) measured using dynamic SPECT imaging and kinetic modeling is an indicator of myocardial blood flow.

Key Words: cardiac SPECT • 99mTc-teboroxime • kinetic modeling




This article has been cited by other articles:


Home page
JNMHome page
H. Iida, T. Hayashi, S. Eberl, and H. Saji
Quantification in SPECT Cardiac Imaging
J. Nucl. Med., January 1, 2003; 44(1): 40 - 42.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.